Her primary scientific interests are in TLR3, Immunology, Virology, Toll-like receptor and Tumor necrosis factor alpha. TLR3 is a subfield of Receptor that Lena Alexopoulou studies. Her Inflammation, Immune system, Anti-dsDNA antibodies and Antibody study in the realm of Immunology connects with subjects such as Toll-Like Receptor 9.
Her research in Virology tackles topics such as Innate immune system which are related to areas like RNA and Orthomyxoviridae. Her Tumor necrosis factor alpha study integrates concerns from other disciplines, such as Colitis, Inflammatory bowel disease and Antigen. Her Cell biology research incorporates themes from TLR7 and Dendritic cell.
The scientist’s investigation covers issues in Immunology, Innate immune system, Receptor, Immune system and TLR3. In the subject of general Immunology, her work in Inflammation, Tumor necrosis factor alpha, Toll-like receptor and TLR7 is often linked to TLR9, thereby combining diverse domains of study. Lena Alexopoulou has included themes like RNA, Signal transduction, Cytokine and Microbiology in her Innate immune system study.
Her Receptor research includes themes of Acquired immune system, Molecular biology, Gene targeting and Cell biology. Her TLR3 research includes elements of Virus, Virology, Downregulation and upregulation and Lung. Her work on Encephalitis and Flavivirus as part of general Virology study is frequently connected to RNA silencing, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
Lena Alexopoulou mainly investigates Innate immune system, TLR7, Immune system, Autoimmunity and Systemic lupus erythematosus. Her research integrates issues of Immunofluorescence Microscopy, Pathogen and Internalization in her study of Innate immune system. Her TLR7 study is focused on Immunology in general.
Her Immunology research is multidisciplinary, incorporating elements of Small interfering RNA, Gene knockdown and Virology. Her Immune system research is multidisciplinary, incorporating perspectives in Receptor and Intracellular, Cell biology. She combines subjects such as Tumor necrosis factor alpha, Myeloid, Cancer research, Pathogenesis and Germinal center with her study of Systemic lupus erythematosus.
Lena Alexopoulou focuses on TLR7, Autoimmune disease, Autoantibody, Immunology and Systemic lupus erythematosus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.
Lena Alexopoulou;Agnieszka Czopik Holt;Ruslan Medzhitov;Richard A. Flavell.
Nature (2001)
Recognition of single-stranded RNA viruses by Toll-like receptor 7
Jennifer M. Lund;Lena Alexopoulou;Ayuko Sato;Margaret Karow.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis
Tian Wang;Terrence Town;Lena Alexopoulou;Lena Alexopoulou;John F Anderson.
Nature Medicine (2004)
Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection
Koichi Tabeta;Philippe Georgel;Edith Janssen;Xin Du.
Proceedings of the National Academy of Sciences of the United States of America (2004)
Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response.
M Pasparakis;L Alexopoulou;V Episkopou;G Kollias.
Journal of Experimental Medicine (1996)
Toll-like receptor 3 promotes cross-priming to virus-infected cells
Oliver Schulz;Sandra S. Diebold;Margaret Chen;Tanja I. Näslund.
Nature (2005)
Viral infection switches non-plasmacytoid dendritic cells into high interferon producers
Sandra S Diebold;Maria Montoya;Hermann Unger;Lena Alexopoulou.
Nature (2003)
Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia.
Ronan Le Goffic;Ronan Le Goffic;Viviane Balloy;Viviane Balloy;Micheline Lagranderie;Lena Alexopoulou;Lena Alexopoulou.
PLOS Pathogens (2006)
Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus
Sean R. Christensen;Michael Kashgarian;Lena Alexopoulou;Richard A. Flavell.
Journal of Experimental Medicine (2005)
Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice
Lena Alexopoulou;Venetta Thomas;Markus Schnare;Yves Lobet.
Nature Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Yale University
National and Kapodistrian University of Athens
University of Cologne
Yale University
University of Southern California
Centre d’Immunologie de Marseille-Luminy
Osaka University
Centre d’Immunologie de Marseille-Luminy
Cincinnati Children's Hospital Medical Center
The University of Texas Southwestern Medical Center
University of Paderborn
RMIT University
University of Würzburg
University of Castilla-La Mancha
University of Barcelona
Kyoto University
Kyoto University
University of Massachusetts Amherst
University of Leeds
University Health Network
Monash University
University of Tennessee at Knoxville
Johnson & Johnson (Netherlands)
Cedars-Sinai Medical Center
Vrije Universiteit Amsterdam
Université Paris Cité